CS
SNY icon

Cannell & Spears’s Sanofi SNY Stock Holding History

Cannell & Spears’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,204
Closed -$494K – 135
2016
Q4 		$494K Sell
12,204
-876
-7% -$34.5K 0.06% 82
2016
Q3 		$500K Hold
13,080
– – 0.06% 79
2016
Q2 		$547K Buy
+13,080
New +$536K 0.07% 70

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cannell & Spears's SNY Position: Q1 2017 in Review

Cannell & Spears sold out of Sanofi (SNY) in Q1 2017, closing a stake of 12,204 shares — an estimated $494K sold.

Cannell & Spears first reported a position in SNY in Q2 2016 and held it in 3 quarters. The position peaked at $547K in Q2 2016. 454 funds tracked by Wall St. Rank hold SNY as of Q1 2017.

  • Cannell & Spears reported no remaining Sanofi position as of Q1 2017 after selling out during the quarter.
  • Cannell & Spears sold 12,204 Sanofi shares in Q1 2017, an estimated $494K.
  • Cannell & Spears first reported a position in Sanofi in Q2 2016 and held it in 3 quarters.
  • Cannell & Spears's Sanofi position peaked at $547K in Q2 2016.
  • 454 funds tracked by Wall St. Rank held Sanofi as of Q1 2017.

Based on Cannell & Spears's 13F filing for Q1 2017, filed 10 May 2017.